CT Colonography Systems Market Seen Reaching $1.69 Billion by 2030

The global computed tomography colonography systems market is projected to grow from $1.22 billion in 2026 to $1.69 billion by 2030, driven by colorectal cancer screening, AI-assisted imaging and demand for non-invasive diagnostics. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - CT colonography systems are becoming a larger part of colorectal screening as healthcare systems look for safer, less invasive diagnostic tools. - The market’s growth signals continued spending on imaging technology tied to early cancer detection and preventive care. - Expanding access to diagnostic imaging could improve detection of colorectal abnormalities such as polyps and tumors.

What happened: - The Business Research Company projected the global computed tomography (CT) colonography systems market will rise from $1.22 billion in 2026 to $1.69 billion by 2030. - The report said the market grew from $1.12 billion in 2025 to an estimated $1.22 billion in 2026, an 8.9% CAGR. - The forecast period through 2030 implies an 8.5% CAGR. - The report was released as part of The Business Research Company’s Computed Tomography (CT) Colonography Systems Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - A free sample is available here. - The full report is available here.

The details: - CT colonography systems use CT scanning to produce detailed cross-sectional images of the colon and rectum. - The systems are used to screen for colorectal abnormalities, including polyps, tumors and other intestinal conditions. - CT colonography offers a non-invasive alternative to traditional colonoscopy. - The report tied historical growth to rising colorectal disease cases, growing awareness of early cancer detection, broader use of advanced diagnostic imaging, better healthcare infrastructure and a shift toward minimally invasive testing. - The forecast period is supported by demand for precision diagnostics, AI-assisted imaging tools, higher investment in imaging infrastructure, preventive screening programs and broader access in emerging markets. - Expected trends include wider acceptance of non-invasive colorectal screening, preference for low-radiation imaging, focus on early detection, adoption of high-resolution imaging systems and better diagnosis of gastrointestinal conditions. - The report said increasing colorectal cancer prevalence is a key market driver. - Lifestyle factors cited include low-fiber diets, higher consumption of processed and red meats, and sedentary habits. - The American Cancer Society reported 3,617,246 colorectal cancer screenings in the US in 2024, up from 3,306,873 in 2023. - The report also pointed to rising demand for non-invasive diagnostics that reduce discomfort and procedural risk. - The UK National Health Service reported 11.4 million cancer-related diagnostic tests in 2024, up 2.8% from 11.1 million in 2023. - During the same period, referrals for chest X-rays, pelvic ultrasounds and kidney ultrasounds also increased. - North America held the largest market share in 2025. - Asia-Pacific is projected to grow at the fastest pace during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The market outlook reflects a broader shift toward screening tools that reduce patient friction while preserving diagnostic accuracy. - AI-assisted imaging and low-radiation systems appear positioned to benefit from hospital investment and preventive-care programs. - The regional split suggests mature demand in North America and faster adoption potential in Asia-Pacific as diagnostic access expands.

What's next: - The report expects continued uptake of non-invasive colorectal screening as healthcare providers prioritize earlier detection. - Further gains will likely depend on imaging infrastructure investment, wider preventive screening and broader adoption of high-resolution and AI-enabled systems. - The Business Research Company said its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - More information is available through the company’s LinkedIn page.

The bottom line: - CT colonography systems are moving from a niche imaging option toward a faster-growing screening market, with demand anchored by colorectal cancer detection and non-invasive diagnostics.